We use cookies to improve your experience. By your continued use of this site you accept such use. To change your settings please see our Privacy Policy.
I accept

29 Mar. 2023

Focusing on Advanced Primary Ovarian Cancer Treatment, OEP Enters into an Exclusive License and Distribution Agreement of Oregovomab in Taiwan

Back